AU Patent

AU780505B2 — Sustained-release formulations for treating CNS-mediated disorders

Assigned to Shire NPS Pharmaceuticals Inc · Expires 2005-03-24 · 21y expired

What this patent protects

Patent listed against pramipexole-dihydrochloride.

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: AU780505B2
Jurisdiction: AU
Classification: —
Expires: 2005-03-24
Drug substance claim: No
Drug product claim: No
Assignee: Shire NPS Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.